Robert Grubb to Early Detection of Cancer
This is a "connection" page, showing publications Robert Grubb has written about Early Detection of Cancer.
Connection Strength
1.460
-
Prostate Cancer: Update on Early Detection and New Biomarkers. Mo Med. 2018 Mar-Apr; 115(2):132-134.
Score: 0.445
-
Screening for cancer: lessons learned from the prostate, lung, colorectal, and ovarian cancer screening trial. Eur Urol. 2015 Oct; 68(4):545-6.
Score: 0.366
-
Risk of Prostate Cancer-related Death Following a Low PSA Level in the PLCO Trial. Cancer Prev Res (Phila). 2020 04; 13(4):367-376.
Score: 0.127
-
Extended follow-up for prostate cancer incidence and mortality among participants in the Prostate, Lung, Colorectal and Ovarian randomized cancer screening trial. BJU Int. 2019 05; 123(5):854-860.
Score: 0.117
-
Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years. Cancer. 2017 Feb 15; 123(4):592-599.
Score: 0.102
-
Earlier prostate-specific antigen testing in African American men--Clinical support for the recommendation. Urol Oncol. 2015 Jul; 33(7):330.e9-17.
Score: 0.091
-
Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans? Urol Oncol. 2014 Jan; 32(1):34.e9-18.
Score: 0.079
-
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J Natl Cancer Inst. 2012 Jan 18; 104(2):125-32.
Score: 0.073
-
Predicting risk of bladder cancer using clinical and demographic information from prostate, lung, colorectal, and ovarian cancer screening trial participants. Cancer Epidemiol Biomarkers Prev. 2013 Dec; 22(12):2241-9.
Score: 0.021
-
Association between race and follow-up diagnostic care after a positive prostate cancer screening test in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer. 2013 Jun 15; 119(12):2223-9.
Score: 0.020
-
Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Cancer Epidemiol. 2012 Dec; 36(6):e401-6.
Score: 0.019